CFT-2718

N/A

Report date: 2022/12/27 18:19:59

NME

Base Information

Drug NameCFT-2718

Drug Alias NameCFT-2718

ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)

Mechanisms of ActionBromodomain-containing protein 4 inhibitors

TargetsBromodomain-containing protein 4

Therapy Area/IndicationsSmall Cell Lung CarcinomaPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesC4 Therapeutics Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung CarcinomaPancreatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A